Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8337839 High affinity human antibodies to human IL-4 receptor

Patent 8337839 was granted and assigned to Regeneron Pharmaceuticals, Inc. on December, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8337839

Patent Inventor Names

Jeanette L. Fairhurst0

Joel H. Martin0

Nicholas J. Papadopoulos0

Tammy T. Huang0

Date of Patent

December 25, 2012

Patent Application Number

13287151

Date Filed

November 2, 2011

Patent Citations Received

‌

US Patent 11866503 Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor

‌

US Patent 11964016 Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy

‌

US Patent 11926670 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

‌

US Patent 12090201 Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody

‌

US Patent 11771743 Methods for preventing or treating allergy by administering an IL-4R antagonist

Patent Primary Examiner

‌

Stephen Rawlings

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8337839 High affinity human antibodies to human IL-4 receptor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API